Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction.
dc.contributor.author | O'Connell, K | |
dc.contributor.author | Boo, T W | |
dc.contributor.author | Keady, D | |
dc.contributor.author | Niriain, U | |
dc.contributor.author | O'Donovan, D | |
dc.contributor.author | Commane, M | |
dc.contributor.author | Faherty, C | |
dc.contributor.author | Cormican, M | |
dc.date.accessioned | 2011-07-20T11:14:56Z | |
dc.date.available | 2011-07-20T11:14:56Z | |
dc.date.issued | 2011-04 | |
dc.identifier.citation | Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction. 2011, 77 (4):338-42 J. Hosp. Infect. | en |
dc.identifier.issn | 1532-2939 | |
dc.identifier.pmid | 21330007 | |
dc.identifier.doi | 10.1016/j.jhin.2010.12.012 | |
dc.identifier.uri | http://hdl.handle.net/10147/136381 | |
dc.description.abstract | Respiratory syncytial virus (RSV) is a potentially life-threatening infection in premature infants. We report an outbreak involving four infants in the neonatal intensive care unit (NICU) of our hospital that occurred in February 2010. RSV A infection was confirmed by real-time polymerase chain reaction. Palivizumab was administered to all infants in the NICU. There were no additional symptomatic cases and repeat RSV surveillance confirmed that there was no further cross-transmission within the unit. The outbreak highlighted the infection control challenge of very high bed occupancy in the unit and the usefulness of molecular methods in facilitating detection and management. | |
dc.language.iso | en | en |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/21330007 | en |
dc.subject.mesh | Antibodies, Monoclonal | |
dc.subject.mesh | Antiviral Agents | |
dc.subject.mesh | Cross Infection | |
dc.subject.mesh | DNA, Viral | |
dc.subject.mesh | Disease Outbreaks | |
dc.subject.mesh | Female | |
dc.subject.mesh | Genotype | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Infant | |
dc.subject.mesh | Infant, Newborn | |
dc.subject.mesh | Infection Control | |
dc.subject.mesh | Intensive Care, Neonatal | |
dc.subject.mesh | Polymerase Chain Reaction | |
dc.subject.mesh | Respiratory Syncytial Virus Infections | |
dc.subject.mesh | Respiratory Syncytial Virus, Human | |
dc.title | Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction. | en |
dc.type | Article | en |
dc.contributor.department | Department of Clinical Microbiology, University College Hospital, Galway, Ireland. karinaoconnell@gmail.com | en |
dc.identifier.journal | The Journal of hospital infection | en |
dc.description.province | Connacht | |
html.description.abstract | Respiratory syncytial virus (RSV) is a potentially life-threatening infection in premature infants. We report an outbreak involving four infants in the neonatal intensive care unit (NICU) of our hospital that occurred in February 2010. RSV A infection was confirmed by real-time polymerase chain reaction. Palivizumab was administered to all infants in the NICU. There were no additional symptomatic cases and repeat RSV surveillance confirmed that there was no further cross-transmission within the unit. The outbreak highlighted the infection control challenge of very high bed occupancy in the unit and the usefulness of molecular methods in facilitating detection and management. |